In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


HealthCare Royalty Partners

Latest From HealthCare Royalty Partners

Financings Of The Fortnight: In The Aftermath Of Facebook IPO, Kythera Steps Up, TVAX And Cancer Genetics Back Off

Plus news on recent financing activity by TVM Capital, Royalty Pharma, Prosonix and Sangart.

BioPharmaceutical Business Strategies

Financings Of The Fortnight Hopes 2011 Didn’t Set A (Low) Fundraising Benchmark For 2012

Plus news on recent financings by Warp Drive Bio, Synageva BioPharma, Elevation Pharmaceuticals and Acceleron Pharma.

Business Strategies

In Long Venture Downturn, Flagship And Canaan Are In The Money

Two veteran life-science venture firms are pushing forward with new funds even as many of their peers can't persuade backers to open their wallets.

Business Strategies

Cosmetic Dermatology Thrives in Spite of Economy

While other medical device sectors, such as orthopedics and invasive plastic surgery, experienced a downturn in elective procedures in 2009, cosmetic dermatology procedures--including Botox and facial filler injections--continue on their upward trend. This fact was emphasized by the record attendance at the American Academy of Dermatology summer meeting held in Chicago in August 2010.
Medical Device
See All